Utah Medical Products Crecimiento futuro
Future controles de criterios 0/6
Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Utah Medical Products.
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Medical Equipment | 17.1% |
Tasa de crecimiento de los ingresos | n/a |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | None |
Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Aug 06Utah Medical Products: An Attractive, But Speculative, Prospect
Mar 22Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Feb 09Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Dec 13Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Nov 23Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30
Nov 03Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295
Aug 28Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?
Mar 04Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295
Feb 10A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)
Jan 11Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29
Aug 08Utah Medical Products declares $0.29 dividend
Aug 02Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M
Jul 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
May 14Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29
Feb 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
Feb 12Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital
Sep 28Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28
Aug 06Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation
May 01Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?
Mar 26Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital
Mar 02Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 11Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain
Jan 27Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?
Jan 13Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?
Dec 29Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?
Dec 15Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?
Nov 30Utah Medical Products declares $0.285 dividend
Nov 03En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Utah Medical Products no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.
Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.
Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
9/30/2024 | 44 | 15 | 17 | 17 | N/A |
6/30/2024 | 47 | 16 | 18 | 18 | N/A |
3/31/2024 | 49 | 16 | 20 | 21 | N/A |
12/31/2023 | 50 | 17 | 22 | 22 | N/A |
9/30/2023 | 51 | 17 | 22 | 23 | N/A |
6/30/2023 | 52 | 17 | 22 | 23 | N/A |
3/31/2023 | 52 | 17 | 22 | 23 | N/A |
12/31/2022 | 52 | 16 | 20 | 21 | N/A |
9/30/2022 | 52 | 16 | 19 | 20 | N/A |
6/30/2022 | 51 | 16 | 20 | 21 | N/A |
3/31/2022 | 50 | 15 | 20 | 21 | N/A |
12/31/2021 | 49 | 15 | 21 | 21 | N/A |
9/30/2021 | 48 | 14 | 22 | 22 | N/A |
6/30/2021 | 46 | 13 | 21 | 21 | N/A |
3/31/2021 | 42 | 11 | 20 | 20 | N/A |
12/31/2020 | 42 | 11 | 19 | 20 | N/A |
9/30/2020 | 42 | 12 | 19 | 20 | N/A |
6/30/2020 | 44 | 13 | 20 | 21 | N/A |
3/31/2020 | 47 | 15 | 18 | 19 | N/A |
12/31/2019 | 47 | 15 | -4 | 17 | N/A |
9/30/2019 | 45 | 14 | -6 | 16 | N/A |
6/30/2019 | 43 | 17 | -7 | 14 | N/A |
3/31/2019 | 42 | 18 | -5 | 16 | N/A |
12/31/2018 | 42 | 19 | 16 | 17 | N/A |
9/30/2018 | 42 | 13 | 15 | 17 | N/A |
6/30/2018 | 42 | 10 | N/A | 17 | N/A |
3/31/2018 | 42 | 9 | N/A | 16 | N/A |
12/31/2017 | 41 | 9 | N/A | 17 | N/A |
9/30/2017 | 40 | 14 | N/A | 16 | N/A |
6/30/2017 | 40 | 13 | N/A | 15 | N/A |
3/31/2017 | 39 | 12 | N/A | 15 | N/A |
12/31/2016 | 39 | 12 | N/A | 15 | N/A |
9/30/2016 | 40 | 13 | N/A | 15 | N/A |
6/30/2016 | 40 | 13 | N/A | 16 | N/A |
3/31/2016 | 40 | 12 | N/A | 16 | N/A |
12/31/2015 | 40 | 12 | N/A | 14 | N/A |
9/30/2015 | 41 | 12 | N/A | 14 | N/A |
6/30/2015 | 41 | 11 | N/A | 15 | N/A |
3/31/2015 | 41 | 11 | N/A | 16 | N/A |
12/31/2014 | 41 | 11 | N/A | 15 | N/A |
9/30/2014 | 41 | 12 | N/A | 14 | N/A |
6/30/2014 | 40 | 12 | N/A | 13 | N/A |
3/31/2014 | 40 | 11 | N/A | 12 | N/A |
12/31/2013 | 40 | 11 | N/A | 12 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de UTMD es superior a la tasa de ahorro (2.6%).
Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de UTMD crezcan más rápidamente que el mercado US
Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de UTMD crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de UTMD crezcan más rápidamente que el mercado de US.
Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de UTMD crezcan a un ritmo superior a 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de UTMD se prevé que sea elevada dentro de 3 años.